These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16639740)

  • 1. Iatrogenic botulism in an amateur weight-lifter.
    Duffey P; Brown C
    Mov Disord; 2006 Jul; 21(7):1056. PubMed ID: 16639740
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe botulism after focal injection of botulinum toxin.
    Souayah N; Karim H; Kamin SS; McArdle J; Marcus S
    Neurology; 2006 Nov; 67(10):1855-6. PubMed ID: 17130423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuromuscular blockade with botulinum toxin. From toxin to therapeutic agent].
    Einecke D
    MMW Fortschr Med; 2001 May; 143 Suppl 2():95-6. PubMed ID: 11434276
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of the spastic drop foot with botulinum toxin type A in adult patients].
    Voller B; Földy D; Hefter H; Auff E; Schnider P
    Wien Klin Wochenschr; 2001; 113 Suppl 4():25-9. PubMed ID: 15506049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient erectile dysfunction associated with intramuscular injection of botulinum toxin type A.
    Papadonikolakis AS; Vekris MD; Kostas JP; Korompilias AV; Soucacos PN
    J South Orthop Assoc; 2002; 11(2):116-8. PubMed ID: 12741592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Persistent injury to an ocular motor muscle secondary to injection of botulinum toxin].
    Gómez-Argüelles JM; Sebastián-de la Cruz F
    Rev Neurol; 2008 Mar 1-15; 46(5):318-9. PubMed ID: 18351572
    [No Abstract]   [Full Text] [Related]  

  • 7. Iatrogenic botulism after botulinum toxin type A injections.
    Coban A; Matur Z; Hanagasi HA; Parman Y
    Clin Neuropharmacol; 2010 May; 33(3):158-60. PubMed ID: 20150804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A (Botox) in the treatment of migraine and other headaches.
    Troost BT
    Expert Rev Neurother; 2004 Jan; 4(1):27-31. PubMed ID: 15853612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2008 Feb; 101(4):515-6; author reply 516-7. PubMed ID: 18234066
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of spastic equinus gait with botulinum toxin A: Does dose matter? Analysis of a clinical cohort.
    Sätilä HK; Pietikäinen T; Lehtonen-Räty P; Koivikko M; Autti-Rämö I
    Neuropediatrics; 2006 Dec; 37(6):344-9. PubMed ID: 17357036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The application of botulinum toxin type A in the treatment of spastic paraparesis].
    Sobolewski P
    Przegl Lek; 2007; 64 Suppl 2():3-7. PubMed ID: 17953270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary.
    De Almeida AR
    Dermatol Surg; 2009 Dec; 35(12):1907. PubMed ID: 20050146
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuralgic amyotrophy following botulinum toxin injection.
    Alcalay RN; Simões RM; Feigin A; Frucht S
    Parkinsonism Relat Disord; 2010 May; 16(4):301-2. PubMed ID: 19815448
    [No Abstract]   [Full Text] [Related]  

  • 15. Iatrogenic botulism in a child with spastic quadriparesis.
    Partikian A; Mitchell WG
    J Child Neurol; 2007 Oct; 22(10):1235-7. PubMed ID: 17940253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
    Casserly P; Timon C
    J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J; Kramer G; Jakse G
    BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of botulinum dosage to duration of side effects and normal voice in adductor spasmodic dysphonia.
    Chang CY; Chabot P; Thomas JP
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):894-9. PubMed ID: 17547976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.
    Karsenty G; Elzayat E; Delapparent T; St-Denis B; Lemieux MC; Corcos J
    J Urol; 2007 Mar; 177(3):1011-4. PubMed ID: 17296399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.